Zepbound 15MG/0.5ML 4S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9YM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,333
Award facts
- Contract value 100% obligated
- $55,332.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $55,332.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 15mg/0.5ml (tirzepatide, a GLP-1 receptor agonist used for weight management) with an ultimate completion date of February 17, 2026. This non-competitive delivery order was awarded on January 19, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order aligns with the company's extensive portfolio of pharmaceutical supply agreements with the DLA, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The non-set-aside designation reflects the contractor's ability to compete effectively on a full and open basis for federal pharmaceutical contracts.
Quick answers
Who was awarded contract SPE2DR26FW9YM?
SPE2DR26FW9YM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 19, 2026.
How much is contract SPE2DR26FW9YM worth?
The government has obligated $55,333 on SPE2DR26FW9YM.
Is contract SPE2DR26FW9YM an order under another contract?
Yes. SPE2DR26FW9YM is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9YM competed?
The extent of competition for SPE2DR26FW9YM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award